Ge-BuPub Date : 1900-01-01DOI: 10.35351/gebu.nl.2021.12.23
FM Helmerhorst, A. van Hylckama Vlieg, Marielle Nieuwhof
{"title":"Nieuwe orale anticonceptiepil met estetrol","authors":"FM Helmerhorst, A. van Hylckama Vlieg, Marielle Nieuwhof","doi":"10.35351/gebu.nl.2021.12.23","DOIUrl":"https://doi.org/10.35351/gebu.nl.2021.12.23","url":null,"abstract":"","PeriodicalId":307580,"journal":{"name":"Ge-Bu","volume":"20 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"1900-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"117156683","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Ge-BuPub Date : 1900-01-01DOI: 10.35351/gebu.nl.2020.6-7.12
F. van Stiphout, LL Krens, M. Bulatović-Ćalasan, TM Bosch
{"title":"Geneesmiddelen bij COVID-19","authors":"F. van Stiphout, LL Krens, M. Bulatović-Ćalasan, TM Bosch","doi":"10.35351/gebu.nl.2020.6-7.12","DOIUrl":"https://doi.org/10.35351/gebu.nl.2020.6-7.12","url":null,"abstract":"","PeriodicalId":307580,"journal":{"name":"Ge-Bu","volume":"137 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"1900-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"122789524","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Ge-BuPub Date : 1900-01-01DOI: 10.35351/gebu.nl.2022.6.12
R. Middelburg
{"title":"Is apixaban effectiever en veiliger dan rivaroxaban?","authors":"R. Middelburg","doi":"10.35351/gebu.nl.2022.6.12","DOIUrl":"https://doi.org/10.35351/gebu.nl.2022.6.12","url":null,"abstract":"","PeriodicalId":307580,"journal":{"name":"Ge-Bu","volume":"26 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"1900-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"116726826","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Ge-BuPub Date : 1900-01-01DOI: 10.35351/gebu.nl.2020.4.5
S. Borgsteede, M. Diesveld, S. Klerk, K. Pham, S. Schoenmakers, J. Versmissen, M. Lafeber
{"title":"Negatieve invloed geneesmiddelen op COVID-19","authors":"S. Borgsteede, M. Diesveld, S. Klerk, K. Pham, S. Schoenmakers, J. Versmissen, M. Lafeber","doi":"10.35351/gebu.nl.2020.4.5","DOIUrl":"https://doi.org/10.35351/gebu.nl.2020.4.5","url":null,"abstract":"","PeriodicalId":307580,"journal":{"name":"Ge-Bu","volume":"1 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"1900-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"129324573","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Ge-BuPub Date : 1900-01-01DOI: 10.35351/gebu.2022.4.8
E. Schwarz
{"title":"Amoxicillin for children with pneumonia","authors":"E. Schwarz","doi":"10.35351/gebu.2022.4.8","DOIUrl":"https://doi.org/10.35351/gebu.2022.4.8","url":null,"abstract":"","PeriodicalId":307580,"journal":{"name":"Ge-Bu","volume":"125 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"1900-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"121543245","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Ge-BuPub Date : 1900-01-01DOI: 10.35351/gebu.2019.4.9
L. Stolk
{"title":"New drug: dimethyl fumarate to treat psoriasis","authors":"L. Stolk","doi":"10.35351/gebu.2019.4.9","DOIUrl":"https://doi.org/10.35351/gebu.2019.4.9","url":null,"abstract":"Dimethyl fumarate (Skilarence®) was newly registered in 2017 for the treatment of psoriasis. This is not a new drug, as it has been available as an unlicensed product for decades. After the registration, the drug was made more expensive. Its shortterm effectiveness for the treatment of psoriasis has now been proven in randomised research. There have been no studies of its effectiveness in the longer term. Its frequent gastrointestinal adverse effects limit the suitability of dimethyl fumarate.","PeriodicalId":307580,"journal":{"name":"Ge-Bu","volume":"188 4","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"1900-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"113980540","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}